Hao Yi Sheng Pharmaceutical Will Build First cGMP Plant In Sichuan
This article was originally published in PharmAsia News
Executive Summary
Hao Yi Sheng (Good Doctor) Pharmaceutical recently held a ground-breaking ceremony in the Anxian Industrial Park in Mianyang city, in Sichuan province. The company will invest RMB 380 million to build its first certified cGMP-standard production base in the southwest of China. China is currently one of the main manufacturers and exporters of active pharmaceutical ingredients in the world, with a 20 percent share of the global market. The goal of building this cGMP plant is to have the capacity to produce high value-added APIs, and to supply the European and U.S. markets. India currently produces more than 260 kinds of cGMP-certified APIs, while China makes less than 50. (Click here for more